Viking Therapeutics (VKTX) Closes Upsized Stock and 2.00% Convertible Notes Offerings, ~$575M Gross

Viking Therapeutics closed upsized offerings of 9,035,714 shares at $35.00 and $258.75M of 2.00% notes due 2032, with full over-allotments exercised, for gross proceeds of about $575.0M and estimated net proceeds of about $547.8M.Material DetailsContext by AI AnalystThis is a financing move to fund…